Imaging modalities and treatment of paediatric upper tract urolithiasis: A systematic review and update on behalf of the EAU urolithiasis guidelines panel.


Journal

Journal of pediatric urology
ISSN: 1873-4898
Titre abrégé: J Pediatr Urol
Pays: England
ID NLM: 101233150

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 19 01 2020
revised: 29 06 2020
accepted: 02 07 2020
pubmed: 3 8 2020
medline: 22 6 2021
entrez: 3 8 2020
Statut: ppublish

Résumé

Prompt diagnosis and treatment of paediatric urolithiasis are required to avoid long term sequelae of renal damage. To systematically review the literature regarding the diagnostic imaging modalities and treatment approaches for paediatric urolithiasis. PubMed, Science Direct, Scopus and Web of Science were systematically searched from January 1980-January 2019. 76 full-text articles were included. Ultrasound and Kidney-Ureter-Bladder radiography are the baseline diagnostic examinations. Non-contrast Computed Tomography (CT) is the second line choice with high sensitivity (97-100%) and specificity (96-100%). Magnetic Resonance Urography accounts only for 2% of pediatric stone imaging studies. Expectant management for single, asymptomatic lower pole renal stones is an acceptable initial approach, especially in patients with non-struvite, non-cystine stones<7 mm. Limited studies exist on medical expulsive therapy as off-label treatment. Extracorporeal shock wave lithotripsy (SWL) is the first-line treatment with overall stone free rates (SFRs) of 70-90%, retreatment rates 4-50% and complication rates up to 15%. Semi-rigid ureteroscopy is effective with SFRs of 81-98%, re-treatment rates of 6.3-10% and complication rates of 1.9-23%. Flexible ureteroscopy has shown SFRs of 76-100%, retreatment rates of 0-19% and complication rates of 0-28%. SFRs after first and second-look percutaneous nephrolithotomy (PNL) are 70.1-97.3% and 84.6-97.5%, respectively with an overall complication rate of 20%. Open surgery is seldom used, while laparoscopy is effective for stones refractory to SWL and PNL. Limited data exist for robot-assisted management. In the initial assessment of paediatric urolithiasis, US is recommended as first imaging modality, while non-contrast CT is the second option. SWL is recommended as first line treatment for renal stones <20 mm and for ureteral stones<10 mm. Ureteroscopy is a feasible alternative both for ureteral stones not amenable to SWL as well as for renal stones <20 mm (using flexible). PNL is recommended for renal stones >20 mm.

Sections du résumé

BACKGROUND BACKGROUND
Prompt diagnosis and treatment of paediatric urolithiasis are required to avoid long term sequelae of renal damage.
OBJECTIVE OBJECTIVE
To systematically review the literature regarding the diagnostic imaging modalities and treatment approaches for paediatric urolithiasis.
STUDY DESIGN METHODS
PubMed, Science Direct, Scopus and Web of Science were systematically searched from January 1980-January 2019. 76 full-text articles were included.
RESULTS RESULTS
Ultrasound and Kidney-Ureter-Bladder radiography are the baseline diagnostic examinations. Non-contrast Computed Tomography (CT) is the second line choice with high sensitivity (97-100%) and specificity (96-100%). Magnetic Resonance Urography accounts only for 2% of pediatric stone imaging studies. Expectant management for single, asymptomatic lower pole renal stones is an acceptable initial approach, especially in patients with non-struvite, non-cystine stones<7 mm. Limited studies exist on medical expulsive therapy as off-label treatment. Extracorporeal shock wave lithotripsy (SWL) is the first-line treatment with overall stone free rates (SFRs) of 70-90%, retreatment rates 4-50% and complication rates up to 15%. Semi-rigid ureteroscopy is effective with SFRs of 81-98%, re-treatment rates of 6.3-10% and complication rates of 1.9-23%. Flexible ureteroscopy has shown SFRs of 76-100%, retreatment rates of 0-19% and complication rates of 0-28%. SFRs after first and second-look percutaneous nephrolithotomy (PNL) are 70.1-97.3% and 84.6-97.5%, respectively with an overall complication rate of 20%. Open surgery is seldom used, while laparoscopy is effective for stones refractory to SWL and PNL. Limited data exist for robot-assisted management.
CONCLUSIONS CONCLUSIONS
In the initial assessment of paediatric urolithiasis, US is recommended as first imaging modality, while non-contrast CT is the second option. SWL is recommended as first line treatment for renal stones <20 mm and for ureteral stones<10 mm. Ureteroscopy is a feasible alternative both for ureteral stones not amenable to SWL as well as for renal stones <20 mm (using flexible). PNL is recommended for renal stones >20 mm.

Identifiants

pubmed: 32739360
pii: S1477-5131(20)30413-7
doi: 10.1016/j.jpurol.2020.07.003
pii:
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

612-624

Informations de copyright

Copyright © 2020 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest Aleš Petřík has received speaker honoraria from Olympus Czech Group, S.R.O., Cook Medical Europe Ltd., fellowship and travel grants from Astellas and consultant fees from Olympus and Cook Medical; Christian Seitz has received consultant fees from Astellas and speaker honoraria from Rowa Wagner; Andreas Neisius has received fellowships/travel grants from Storz, Wolf, Astellas, Astellas, Boston Scientific, Novartis, Janssen, Eichard Wolf, Karl Storz, consultant fees from Novartis, MSD, Roche, speaker honorarium from Siemens Healthcare, Pfizer, Astellas, Ferring, Boston Scientific Europe, Pfizer, MSD, Boston Scientific and has participated in trials for Bayer, Kendle, Merck, Astellas, MSD, Kendle; Kay Thomas has participated in trials for TISU.

Auteurs

Nikolaos Grivas (N)

Department of Urology, G.Hatzikosta General Hospital, Ioannina, Greece; Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands. Electronic address: nikolaosgrivas@hotmail.com.

Kay Thomas (K)

Department of Urology, Guy's and St Thomas' NHS Foundation Trust, The Stone Unit, London, UK.

Tamsin Drake (T)

Department of Urology, Southmead Hospital, Bristol, UK.

James Donaldson (J)

Department of Urology, Aberdeen Royal Infirmary, Aberdeen, Scotland, UK.

Andreas Neisius (A)

Department of Urology, Hospital of the Brothers of Mercy Trier, Johannes Gutenberg University Mainz, Trier, Germany.

Aleš Petřík (A)

Department of Urology, Region Hospital, Ceske Budejovice, Czech Republic; Dept. of Urology, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.

Yasir Ruhayel (Y)

Department of Urology, Skåne University Hospital, Malmö, Sweden.

Christian Seitz (C)

Department of Urology, Vienna General Hospital, Medical University of Vienna, Vienna, Austria.

Christian Türk (C)

Department of Urology, Hospital of the Sisters of Charity, Vienna, Austria; Urologische Praxis Mit Steinzentrum, Vienna, Austria.

Andreas Skolarikos (A)

Second Department of Urology, Sismanoglio Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH